Annual CAPEX
$2.20 B
+$425.00 M+23.92%
31 December 2023
Summary:
Abbott Laboratories annual capital expenditures is currently $2.20 billion, with the most recent change of +$425.00 million (+23.92%) on 31 December 2023. During the last 3 years, it has risen by +$25.00 million (+1.15%). ABT annual CAPEX is now at all-time high.ABT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$556.00 M
+$23.00 M+4.32%
30 September 2024
Summary:
Abbott Laboratories quarterly capital expenditures is currently $556.00 million, with the most recent change of +$23.00 million (+4.32%) on 30 September 2024. Over the past year, it has dropped by -$4.00 million (-0.71%). ABT quarterly CAPEX is now -41.25% below its all-time high of $946.40 million, reached on 30 September 1998.ABT Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$2.24 B
-$4.00 M-0.18%
30 September 2024
Summary:
Abbott Laboratories TTM capital expenditures is currently $2.24 billion, with the most recent change of -$4.00 million (-0.18%) on 30 September 2024. Over the past year, it has increased by +$185.00 million (+8.99%). ABT TTM CAPEX is now -0.18% below its all-time high of $2.25 billion, reached on 30 June 2024.ABT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.9% | -0.7% | +9.0% |
| 3 y3 years | +1.1% | +20.6% | +15.0% |
| 5 y5 years | +58.0% | +38.6% | +34.2% |
ABT CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +23.9% | -26.4% | +73.2% | -0.2% | +26.3% |
| 5 y | 5 years | at high | +58.0% | -26.4% | +73.2% | -0.2% | +36.9% |
| alltime | all time | at high | +284.2% | -41.3% | +179.8% | -0.2% |
Abbott Laboratories CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $556.00 M(+4.3%) | $2.24 B(-0.2%) |
| June 2024 | - | $533.00 M(+33.9%) | $2.25 B(+1.2%) |
| Mar 2024 | - | $398.00 M(-47.3%) | $2.22 B(+0.8%) |
| Dec 2023 | $2.20 B(+23.9%) | $755.00 M(+34.8%) | $2.20 B(+7.0%) |
| Sept 2023 | - | $560.00 M(+10.5%) | $2.06 B(+4.7%) |
| June 2023 | - | $507.00 M(+33.4%) | $1.96 B(+7.0%) |
| Mar 2023 | - | $380.00 M(-37.7%) | $1.84 B(+3.3%) |
| Dec 2022 | $1.78 B(-5.7%) | $610.00 M(+30.6%) | $1.78 B(-0.2%) |
| Sept 2022 | - | $467.00 M(+23.2%) | $1.78 B(+0.3%) |
| June 2022 | - | $379.00 M(+18.1%) | $1.77 B(-1.9%) |
| Mar 2022 | - | $321.00 M(-47.7%) | $1.81 B(-4.0%) |
| Dec 2021 | $1.89 B(-13.4%) | $614.00 M(+33.2%) | $1.89 B(-3.3%) |
| Sept 2021 | - | $461.00 M(+11.6%) | $1.95 B(-1.8%) |
| June 2021 | - | $413.00 M(+4.0%) | $1.99 B(-10.3%) |
| Mar 2021 | - | $397.00 M(-41.5%) | $2.21 B(+1.7%) |
| Dec 2020 | $2.18 B(+32.9%) | $679.00 M(+36.9%) | $2.18 B(+12.7%) |
| Sept 2020 | - | $496.00 M(-22.7%) | $1.93 B(+5.2%) |
| June 2020 | - | $642.00 M(+78.3%) | $1.84 B(+10.5%) |
| Mar 2020 | - | $360.00 M(-17.1%) | $1.66 B(+1.5%) |
| Dec 2019 | $1.64 B(+17.5%) | $434.00 M(+8.2%) | $1.64 B(-2.0%) |
| Sept 2019 | - | $401.00 M(-14.3%) | $1.67 B(+2.9%) |
| June 2019 | - | $468.00 M(+39.7%) | $1.62 B(+11.7%) |
| Mar 2019 | - | $335.00 M(-28.3%) | $1.45 B(+4.3%) |
| Dec 2018 | $1.39 B(+22.8%) | $467.00 M(+31.9%) | $1.39 B(+9.6%) |
| Sept 2018 | - | $354.00 M(+18.8%) | $1.27 B(+7.7%) |
| June 2018 | - | $298.00 M(+8.4%) | $1.18 B(+3.8%) |
| Mar 2018 | - | $275.00 M(-20.3%) | $1.14 B(+0.3%) |
| Dec 2017 | $1.14 B(+1.2%) | $345.00 M(+31.2%) | $1.14 B(+2.3%) |
| Sept 2017 | - | $263.00 M(+3.1%) | $1.11 B(-4.2%) |
| June 2017 | - | $255.00 M(-6.3%) | $1.16 B(+0.7%) |
| Mar 2017 | - | $272.00 M(-14.7%) | $1.15 B(+2.6%) |
| Dec 2016 | $1.12 B(+1.0%) | $319.00 M(+2.2%) | $1.12 B(+6.8%) |
| Sept 2016 | - | $312.00 M(+26.3%) | $1.05 B(-8.6%) |
| June 2016 | - | $247.00 M(+1.6%) | $1.15 B(+2.8%) |
| Mar 2016 | - | $243.00 M(-2.0%) | $1.12 B(+0.7%) |
| Dec 2015 | $1.11 B(+3.1%) | $248.00 M(-39.7%) | $1.11 B(-3.4%) |
| Sept 2015 | - | $411.00 M(+90.3%) | $1.15 B(+13.2%) |
| June 2015 | - | $216.00 M(-8.1%) | $1.01 B(-4.0%) |
| Mar 2015 | - | $235.00 M(-18.1%) | $1.06 B(-1.9%) |
| Dec 2014 | $1.08 B(-5.9%) | $287.00 M(+3.6%) | $1.08 B(-1.5%) |
| Sept 2014 | - | $277.00 M(+7.4%) | $1.09 B(0.0%) |
| June 2014 | - | $258.00 M(+1.2%) | $1.09 B(-2.9%) |
| Mar 2014 | - | $255.00 M(-15.8%) | $1.13 B(-1.7%) |
| Dec 2013 | $1.15 B(-36.2%) | $303.00 M(+9.4%) | $1.15 B(-6.7%) |
| Sept 2013 | - | $277.00 M(-4.8%) | $1.23 B(-17.1%) |
| June 2013 | - | $291.00 M(+6.2%) | $1.48 B(-8.3%) |
| Mar 2013 | - | $274.00 M(-29.0%) | $1.62 B(-10.0%) |
| Dec 2012 | $1.79 B(+20.4%) | $385.81 M(-27.3%) | $1.79 B(+6.6%) |
| Sept 2012 | - | $530.75 M(+24.8%) | $1.68 B(+4.9%) |
| June 2012 | - | $425.12 M(-6.2%) | $1.60 B(+3.4%) |
| Mar 2012 | - | $453.33 M(+65.3%) | $1.55 B(+4.1%) |
| Dec 2011 | $1.49 B(+46.9%) | $274.24 M(-39.3%) | $1.49 B(-1.1%) |
| Sept 2011 | - | $452.00 M(+21.2%) | $1.51 B(+19.6%) |
| June 2011 | - | $372.96 M(-4.8%) | $1.26 B(+8.6%) |
| Mar 2011 | - | $391.81 M(+34.5%) | $1.16 B(+14.4%) |
| Dec 2010 | $1.02 B(-6.8%) | $291.33 M(+42.1%) | $1.02 B(+4.7%) |
| Sept 2010 | - | $205.09 M(-25.0%) | $969.19 M(-11.3%) |
| June 2010 | - | $273.51 M(+11.6%) | $1.09 B(+1.0%) |
| Mar 2010 | - | $245.14 M(-0.1%) | $1.08 B(-0.6%) |
| Dec 2009 | $1.09 B(-15.4%) | $245.45 M(-25.3%) | $1.09 B(-1.7%) |
| Sept 2009 | - | $328.71 M(+25.1%) | $1.11 B(+0.8%) |
| June 2009 | - | $262.74 M(+4.2%) | $1.10 B(-8.9%) |
| Mar 2009 | - | $252.15 M(-4.7%) | $1.21 B(-6.3%) |
| Dec 2008 | $1.29 B | $264.59 M(-17.3%) | $1.29 B(-11.3%) |
| Sept 2008 | - | $319.81 M(-13.6%) | $1.45 B(-4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2008 | - | $370.34 M(+11.2%) | $1.52 B(-8.5%) |
| Mar 2008 | - | $332.98 M(-22.3%) | $1.66 B(+0.2%) |
| Dec 2007 | $1.66 B(+23.8%) | $428.78 M(+10.6%) | $1.66 B(+7.4%) |
| Sept 2007 | - | $387.58 M(-24.1%) | $1.54 B(+2.3%) |
| June 2007 | - | $510.73 M(+55.2%) | $1.51 B(+9.9%) |
| Mar 2007 | - | $329.12 M(+4.8%) | $1.37 B(+2.5%) |
| Dec 2006 | $1.34 B(+10.8%) | $314.12 M(-10.8%) | $1.34 B(+0.2%) |
| Sept 2006 | - | $352.34 M(-6.1%) | $1.34 B(+7.3%) |
| June 2006 | - | $375.11 M(+26.6%) | $1.24 B(+6.4%) |
| Mar 2006 | - | $296.25 M(-4.9%) | $1.17 B(-3.1%) |
| Dec 2005 | $1.21 B(-6.5%) | $311.65 M(+19.0%) | $1.21 B(-3.7%) |
| Sept 2005 | - | $261.99 M(-12.6%) | $1.25 B(-8.1%) |
| June 2005 | - | $299.71 M(-10.3%) | $1.36 B(+3.2%) |
| Mar 2005 | - | $334.14 M(-6.6%) | $1.32 B(+2.3%) |
| Dec 2004 | $1.29 B(+23.0%) | $357.93 M(-3.8%) | $1.29 B(+9.8%) |
| Sept 2004 | - | $371.92 M(+44.6%) | $1.18 B(+8.0%) |
| June 2004 | - | $257.29 M(-15.5%) | $1.09 B(+1.8%) |
| Mar 2004 | - | $304.49 M(+25.5%) | $1.07 B(+1.9%) |
| Dec 2003 | $1.05 B(-5.0%) | $242.53 M(-14.9%) | $1.05 B(+4.7%) |
| Sept 2003 | - | $284.90 M(+19.8%) | $1.00 B(-2.4%) |
| June 2003 | - | $237.72 M(-16.6%) | $1.03 B(-3.6%) |
| Mar 2003 | - | $284.91 M(+45.9%) | $1.07 B(-3.6%) |
| Dec 2002 | $1.11 B(-5.0%) | $195.34 M(-36.9%) | $1.11 B(-13.1%) |
| Sept 2002 | - | $309.62 M(+12.4%) | $1.27 B(-7.3%) |
| June 2002 | - | $275.57 M(-15.2%) | $1.37 B(+9.7%) |
| Mar 2002 | - | $324.91 M(-10.3%) | $1.25 B(+7.6%) |
| Dec 2001 | $1.16 B(+12.3%) | $362.10 M(-11.7%) | $1.16 B(+4.9%) |
| Sept 2001 | - | $410.22 M(+165.3%) | $1.11 B(+23.7%) |
| June 2001 | - | $154.62 M(-34.7%) | $896.42 M(-13.0%) |
| Mar 2001 | - | $236.77 M(-23.0%) | $1.03 B(-0.5%) |
| Dec 2000 | $1.04 B(-14.0%) | $307.63 M(+55.8%) | $1.04 B(-13.8%) |
| Sept 2000 | - | $197.40 M(-31.7%) | $1.20 B(-5.3%) |
| June 2000 | - | $289.04 M(+19.5%) | $1.27 B(+2.9%) |
| Mar 2000 | - | $241.80 M(-49.0%) | $1.23 B(+2.5%) |
| Dec 1999 | $1.20 B(-3.1%) | $473.88 M(+78.7%) | $1.20 B(+17.3%) |
| Sept 1999 | - | $265.12 M(+4.7%) | $1.03 B(-39.9%) |
| June 1999 | - | $253.19 M(+19.5%) | $1.71 B(+40.4%) |
| Mar 1999 | - | $211.91 M(-28.5%) | $1.22 B(-2.1%) |
| Dec 1998 | $1.24 B(+2.7%) | $296.30 M(-68.7%) | $1.24 B(-12.7%) |
| Sept 1998 | - | $946.40 M(-497.0%) | $1.42 B(+17.7%) |
| June 1998 | - | -$238.40 M(-200.0%) | $1.21 B(-16.5%) |
| Mar 1998 | - | $238.40 M(-50.0%) | $1.45 B(+19.7%) |
| Dec 1997 | $1.21 B(+27.5%) | $477.20 M(-34.8%) | $1.21 B(+21.0%) |
| Sept 1997 | - | $732.40 M(+173.9%) | $999.83 M(+5.4%) |
| Dec 1996 | $949.00 M(-5.8%) | $267.43 M(+21.2%) | $949.00 M(+39.2%) |
| Sept 1996 | - | $220.67 M(-4.5%) | $681.57 M(+47.9%) |
| June 1996 | - | $231.10 M(+0.6%) | $460.90 M(+100.6%) |
| Mar 1996 | - | $229.80 M(-133.0%) | $229.80 M(>+9900.0%) |
| Dec 1993 | - | -$697.00 M(-385.5%) | $0.00(-100.0%) |
| Sept 1993 | - | $244.10 M(+1.2%) | $1.00 B(-0.5%) |
| June 1993 | - | $241.10 M(+13.8%) | $1.01 B(+0.5%) |
| Mar 1993 | - | $211.80 M(-30.6%) | $1.00 B(-0.5%) |
| Dec 1992 | $1.01 B(+30.7%) | $305.40 M(+22.8%) | $1.01 B(+3.6%) |
| Sept 1992 | - | $248.70 M(+5.2%) | $972.60 M(+7.4%) |
| June 1992 | - | $236.30 M(+9.0%) | $905.40 M(+8.7%) |
| Mar 1992 | - | $216.80 M(-19.9%) | $833.00 M(+8.1%) |
| Dec 1991 | $770.60 M(+20.1%) | $270.80 M(+49.2%) | $770.60 M(+12.5%) |
| Sept 1991 | - | $181.50 M(+10.7%) | $684.90 M(+5.8%) |
| June 1991 | - | $163.90 M(+6.2%) | $647.60 M(+1.0%) |
| Mar 1991 | - | $154.40 M(-16.6%) | $641.10 M(-0.0%) |
| Dec 1990 | $641.40 M(+11.9%) | $185.10 M(+28.4%) | $641.40 M(+40.6%) |
| Sept 1990 | - | $144.20 M(-8.4%) | $456.30 M(+46.2%) |
| June 1990 | - | $157.40 M(+1.7%) | $312.10 M(+101.7%) |
| Mar 1990 | - | $154.70 M | $154.70 M |
| Dec 1989 | $573.10 M | - | - |
FAQ
- What is Abbott Laboratories annual capital expenditures?
- What is the all time high annual CAPEX for Abbott Laboratories?
- What is Abbott Laboratories annual CAPEX year-on-year change?
- What is Abbott Laboratories quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Abbott Laboratories?
- What is Abbott Laboratories quarterly CAPEX year-on-year change?
- What is Abbott Laboratories TTM capital expenditures?
- What is the all time high TTM CAPEX for Abbott Laboratories?
- What is Abbott Laboratories TTM CAPEX year-on-year change?
What is Abbott Laboratories annual capital expenditures?
The current annual CAPEX of ABT is $2.20 B
What is the all time high annual CAPEX for Abbott Laboratories?
Abbott Laboratories all-time high annual capital expenditures is $2.20 B
What is Abbott Laboratories annual CAPEX year-on-year change?
Over the past year, ABT annual capital expenditures has changed by +$425.00 M (+23.92%)
What is Abbott Laboratories quarterly capital expenditures?
The current quarterly CAPEX of ABT is $556.00 M
What is the all time high quarterly CAPEX for Abbott Laboratories?
Abbott Laboratories all-time high quarterly capital expenditures is $946.40 M
What is Abbott Laboratories quarterly CAPEX year-on-year change?
Over the past year, ABT quarterly capital expenditures has changed by -$4.00 M (-0.71%)
What is Abbott Laboratories TTM capital expenditures?
The current TTM CAPEX of ABT is $2.24 B
What is the all time high TTM CAPEX for Abbott Laboratories?
Abbott Laboratories all-time high TTM capital expenditures is $2.25 B
What is Abbott Laboratories TTM CAPEX year-on-year change?
Over the past year, ABT TTM capital expenditures has changed by +$185.00 M (+8.99%)